Literature DB >> 30112174

Successful treatment of a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by bone marrow necrosis and acute renal insufficiency: A case report.

Jieyun Xia1, Haiying Sun1, Zhiling Yan1, Feng Zhu1, Kai Zhao1, Kailin Xu1,2.   

Abstract

Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) complicated by bone marrow necrosis (BMN) and acute renal insufficiency (ARI) is rare in clinical practice. The aim of the present study was to summarize the clinical characteristics and treatment methods of a case of Ph+ ALL complicated by BMN and ARI. A 23-year-old male patient presented with pyrexia and a 2-month history of bone pain, and was diagnosed with Ph+ ALL complicated with BMN and ARI on peripheral blood tests, blood biochemistry tests, BM smear and fluorescence in situ hybridization. The patient underwent repeated hemodialysis, imatinib combination and maintenance chemotherapy, followed by allogeneic hematopoietic stem-cell transplantation. Some of the clinical signs and symptoms were alleviated, whereas others disappeared, and renal function was restored to normal. BM aspiration confirmed absence of necrosis and null lymphoblasts. Therefore, timely accurate diagnosis and effective treatment are crucial for patients with Ph+ ALL exhibiting potentially fatal complications.

Entities:  

Keywords:  acute lymphoblastic leukemia; acute renal insufficiency; bone marrow necrosis; chemotherapy; imatinib

Year:  2018        PMID: 30112174      PMCID: PMC6090569          DOI: 10.3892/mco.2018.1661

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  24 in total

1.  Bone marrow necrosis in a girl with Hodgkin's disease.

Authors:  Herwig Lackner; Volker Strenger; Petra Sovinz; Christine Beham-Schmid; Alexander Pilhatsch; Martin Benesch; Wolfgang Schwinger; Raphael Ulreich; Sandrin Schmidt; Christian Urban
Journal:  Support Care Cancer       Date:  2012-07-08       Impact factor: 3.603

2.  Lymphocytic progenitor cell origin and clonal evolution of human B-lineage acute lymphoblastic leukemia.

Authors:  F Davi; C Gocke; S Smith; J Sklar
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

3.  Hyperuricemic acute renal failure.

Authors:  C M Kjellstrand; D C Cambell; B von Hartitzsch; T J Buselmeier
Journal:  Arch Intern Med       Date:  1974-03

4.  Prognosis of critically ill patients with cancer and acute renal dysfunction.

Authors:  Márcio Soares; Jorge I F Salluh; Marilia S Carvalho; Michael Darmon; José R Rocco; Nelson Spector
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

5.  High Risk of Tumor Lysis Syndrome in Symptomatic Patients with Multiple Myeloma with Renal Dysfunction Treated with Bortezomib.

Authors:  Kana Oiwa; Mihoko Morita; Shinji Kishi; Miyuki Okura; Toshiki Tasaki; Yasufumi Matsuda; Katsunori Tai; Naoko Hosono; Takanori Ueda; Takahiro Yamauchi
Journal:  Anticancer Res       Date:  2016-12       Impact factor: 2.480

Review 6.  Tumour lysis syndrome: new therapeutic strategies and classification.

Authors:  Mitchell S Cairo; Michael Bishop
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 7.  Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Authors:  Bertrand Coiffier; Arnold Altman; Ching-Hon Pui; Anas Younes; Mitchell S Cairo
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

8.  Sevelamer Hydrochloride for Tumor Lysis Syndrome-related Hyperphosphatemia.

Authors:  Harsha L Prasada
Journal:  Indian Pediatr       Date:  2015-07       Impact factor: 1.411

9.  Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature.

Authors:  Semra Paydas; Melek Ergin; Fikri Baslamisli; Sinan Yavuz; Suzan Zorludemir; Berksoy Sahin; Filiz A Bolat
Journal:  Am J Hematol       Date:  2002-08       Impact factor: 10.047

10.  An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration.

Authors:  Jerrold Spapen; Karel Fostier; Hendrik De Raeve; Peter Janssens; Herbert Spapen
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.